ArticleMetabolites2025

Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose.

Satoshi Shinozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.